中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2012年
22期
3365-3366
,共2页
支气管哮喘%甲泼尼龙%氨茶碱
支氣管哮喘%甲潑尼龍%氨茶堿
지기관효천%갑발니룡%안다감
Bronchial asthma%Methylprednisolone%Aminophylline
目的 探讨甲泼尼龙联合氨茶碱治疗急性期支气管哮喘的临床效果和安全性.方法 将96例支气管哮喘确诊患者随机分为观察组(50例)和对照组(46例),所有患者均行常规对症支持治疗,在此基础上观察组加用氨茶碱和甲泼尼龙,对照组加用氨茶碱,观察并记录两组治疗效果、起效时间及并发症发生情况.结果 观察组治疗总有效率(98.0%)明显高于对照组(73.9%)(P<0.05),起效时间[(7.3±0.5)h]明显短于对照组[(14.7±2.1)h](P<0.05),并发症发生率(8.0%)明显低于对照组(17.4%)(P<0.05).结论 在采用常规对症支持治疗的基础上加用甲泼尼龙和氨茶碱治疗支气管哮喘急性期患者起效快,疗效确切,安全性好,值得临床推广.
目的 探討甲潑尼龍聯閤氨茶堿治療急性期支氣管哮喘的臨床效果和安全性.方法 將96例支氣管哮喘確診患者隨機分為觀察組(50例)和對照組(46例),所有患者均行常規對癥支持治療,在此基礎上觀察組加用氨茶堿和甲潑尼龍,對照組加用氨茶堿,觀察併記錄兩組治療效果、起效時間及併髮癥髮生情況.結果 觀察組治療總有效率(98.0%)明顯高于對照組(73.9%)(P<0.05),起效時間[(7.3±0.5)h]明顯短于對照組[(14.7±2.1)h](P<0.05),併髮癥髮生率(8.0%)明顯低于對照組(17.4%)(P<0.05).結論 在採用常規對癥支持治療的基礎上加用甲潑尼龍和氨茶堿治療支氣管哮喘急性期患者起效快,療效確切,安全性好,值得臨床推廣.
목적 탐토갑발니룡연합안다감치료급성기지기관효천적림상효과화안전성.방법 장96례지기관효천학진환자수궤분위관찰조(50례)화대조조(46례),소유환자균행상규대증지지치료,재차기출상관찰조가용안다감화갑발니룡,대조조가용안다감,관찰병기록량조치료효과、기효시간급병발증발생정황.결과 관찰조치료총유효솔(98.0%)명현고우대조조(73.9%)(P<0.05),기효시간[(7.3±0.5)h]명현단우대조조[(14.7±2.1)h](P<0.05),병발증발생솔(8.0%)명현저우대조조(17.4%)(P<0.05).결론 재채용상규대증지지치료적기출상가용갑발니룡화안다감치료지기관효천급성기환자기효쾌,료효학절,안전성호,치득림상추엄.
Objective To study the efficacy and safety of treatment with methylprednisolone for acute stage of bronchial asthma.Methods 96 patients diagnosed as bronchial asthma were divided into observation group(50 cases)and control group(46 cases).All the patients were treated with conventional expectant and supporting treatment,and aminophylline and methylprednisolone were added in observation group,while only aminophylline was added in control group.The efficacy,onset time and the incidence of complications were recorded.Results The total effective rate in observation group was higher than that in control group(98.0% vs 73.9%,P<0.05),and the onset time in observation group was shorter than that in control group[(7.3±0.5)h vs(14.7±2.1)h,P<0.05].The rate of complications in observation group was 8.0%,while 17.4% in control group,and the former was lower than the latter(P<0.05).Conclusion Methylprednisolone and aminophylline added to conventional expectant and supporting treatment for bronchial asthma could make the onset time shorter,the curative effect accurate and safety.It was worthy of clinical application.